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Summary
Background: Safe storage of oral methadone at home is an important issue given the risk of accidental paediatric con-
sumption. Pharmacy protocols centre on provision of information to patients relating to general and paediatric dangers 
of methadone and safe storage of methadone in the home. Aim: The study aimed to audit the effectiveness of pharmacy 
provision of information on safety of methadone consumption and storage in the home. Methods: The study involved an 
audit of five criteria relating to patient awareness of general dangers of methadone use and paediatric risks, patient infor-
mation recall on safe storage of methadone in the home; take home methadone dispensing in child resistant containers and 
safe and secured storage of methadone. Audit information was collected using a survey with consecutive adult patients 
attending a specialist methadone clinic over the course of four weeks (n=94), and telephone interviews with dispensing 
pharmacists recorded in the specialist clinic register (n=43). Results: None of the criteria reached a 100% standard. 51% 
reported never being provided with safety information. 97% of patients were aware of the dangers of methadone use, with 
females significantly more aware of dangers of methadone to users. 86% did not place their take-home methadone in a 
locked place. 90% reported they would seek medical help if a child had accidentally consumed methadone. 58% of phar-
macists never questioned patients around storage, but 58% reported counselling patients on safe storage. Conclusions: 
Safe storage of methadone warrants regular and proactive pharmacy provision of information around harms associated 
with methadone.
Key Words: Methadone; paediatric overdose; accidental consumption 
1. Introduction
Addiction to opioids is described as a chronic 
relapsing disorder with permanent metabolic defi-
ciency [11]. Treatment of opioid addiction and detox-
ification employing therapeutic agents centre on the 
oral administration of full or partial opioid agonists 
(i.e. methadone, buprenorphine, LAAM, codeine or 
oral morphine) [3]. Methadone replacement therapy 
is the most frequently prescribed treatment for with-
drawal symptoms associated with heroin and other 
opioids worldwide and with strong evidence for its 
effectiveness in treating opiate withdrawal and pain 
[4, 26]. Methadone is a synthetic, narcotic analgesic 
which has a long duration of action, with plasma half-
life ranging from 13 to 58 hours, allowing a once a 
day dose regimen [18]. Length of stabilisation varies, 
and when tapering incremental dose reductions are 
administered over a course of 7–21 days [33]. Calls 
to scale up availability of methadone maintenance 
treatment are evident in recent times [24,26], with 
low threshold methadone maintenance treatment on 
the increase [40].
1.1. Risks and Requirements for Safe Patient Stor-
age of Methadone
Methadone is not without risks. The toxic and 
potentially lethal dose of methadone is 1mg/kg in an 
opiate naïve patient, with lowest published toxic dose 
ranging from 0.76 to 2mg/kg, and lowest published 
lethal dose of 1.3 mg/kg [16]. Methadone is potential-
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ly lethal even in smaller doses (0.5mg/kg) [36]. Tox-
icity can cause fatality resulting from central nerv-
ous system (CNS) depression, respiratory depression, 
miosis and fatal arrhythmias [18, 38, 44]. Iatrogenic 
methadone toxicity most commonly occurs on com-
mencement of maintenance treatment [9]. Methadone 
poisoning can also be accidental (overdose due to 
abuse of narcotics or by children/elderly) or inten-
tional (therapeutic, suicide or homicide purposes) 
[12, 29]. The majority of methadone related deaths 
are confounded by the presence of other CNS depres-
sants such as benzodiazepines and opiates [28, 38]. 
Studies indicate how addiction, gender, age, suicide 
attempt and presence of psychiatric disorder are 
closely related to methadone poisonings [6, 27, 41]. 
Methadone poisoned patients generally fall into the 
age category of 20-39 years [8, 22, 41]. 
Safe storage of medicines in the patient home 
is an important issue, and particularly in the case of 
oral solutions [5, 30, 42]. Some studies indicate that 
only half of patients store methadone in a safe place 
[7], and often in potentially fatal volumes, particular-
ly for children [30]. Of concern is the availability of 
take home doses to family members and implication 
of methadone in accidental paediatric deaths where 
parents administered the drug (for sedating of fretful 
children or management of neonatal abstinence syn-
drome); did not store carefully or securely, or where 
methadone patients were present in the child’s envi-
ronment [2, 14, 23, 39]. There is potential for child 
abuse among methadone-maintained parents and car-
egivers [15, 21]. Pharmaceutical companies prepare 
methadone solutions with fruit taste, making it attrac-
tive to children. Shadnia et al. [37] have described 
how most accidental poisoning cases occur as a result 
of syrup formulation, particularly by children under 
12 years old when mistaken for water or cough mix-
ture. Accidental intoxication appears to occur most 
commonly with opiate management drugs in children 
less than 3 years old, and with a predominance of 
boys [2, 31]. 
1.2. Dispensing of Take Home Methadone and In-
formation Provision in the Pharmacy 
Supervised consumption of methadone in deliv-
ery centres (for example pharmacies) has contributed 
to reduced levels of deaths [30]. However, dispens-
ing errors contributing to contamination of prescrip-
tion medications such as antibiotics with methadone 
[20] and in dental cocktails [19] are reported. Despite 
implementation of supervised consumption, patients 
generally take home methadone on Saturday, for un-
supervised consumption on Sunday when pharmacies 
are closed [30]. Requirements to store methadone 
safely in the home increase when patients are dis-
pensed in quantities of more than daily instalments, 
and given variations in volume [5]. Given that most 
patients store methadone for at least one day per week 
at home the risk for accidental paediatric consump-
tion is compounded [5, 32]. Use of baby’s bottles for 
dose measurement is also reported [17] with residual 
quantities posing a risk for intoxication [12]. 
Pharmacy professionals are advised to provide 
information and guidance to patients around risks 
associated with methadone and safe secure storage. 
Pharmacy practice auditing of effective patient in-
formation provision relating to safe secure storage, 
dispensing in child resistant containers, provision of 
measurement devices and ongoing patient recall and 
awareness of dangers of methadone and particular 
risks to children are important [5, 30]. 
Given the importance of pharmacy advice and 
dispensing practices with regard to safe storage of 
methadone, we undertook a pharmacy audit to evalu-
ate effectiveness of pharmacy provision of advice in 
Ireland relating to awareness of general and paediatric 
risks, safety of methadone consumption, and storage. 
At the time of the audit in 2015, 9,615 patients were 
receiving opiate replacement treatment. The National 
Poisons Information centre reported on 16 paediatric 
admissions for methadone toxicity in children under 
four years old in the period 2005-2014. To date this 
is the first audit of its kind in Ireland and ultimately 
conducted in order to provide foundation for the de-
sign and implementation of an information leaflet for 
methadone patients and their carers.
2. Methods
2.1. Audit Criteria and Setting 
The audit adhered to a standard audit methodol-
ogy for assessing the effectiveness of pharmacy infor-
mation provision on the methadone and safe storage 
[5, 30], by selection of appropriate criteria and iden-
tification of standards to measure success in achiev-
ing the criteria and was undertaken in Cork, South 
Ireland. The audit assessed adequacy of information 
provision against five criteria.
1. All patients should be aware of the dangers 
of methadone use.
2. All patients should be aware of the particu-
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lar risks to children, especially if they have 
children at home or visiting the home.
3. All patients prescribed methadone should 
recall being given information on its safe 
storage. 
4. All methadone should be dispensed in a 
child resistant container when prescribed for 
home consumption.
5. All patients with methadone at home should 
store it in a safe locked location in a con-
tainer with child resistant caps.
2.2. Standards
The standard setting was agreed by the audit 
team using the following principles.
1. Given the high risks posed by accidental 
methadone overdose criteria 1 –5 were giv-
en a 100% standard.
2.3. Development of Instruments
The questionnaire for anonymous patient com-
pletion was designed by the team based on an exten-
sive consultation with the literature, and the prior au-
dits undertaken in the UK [5,30]. The content of the 
questionnaire incorporated the following aspects; 
• daily volume of methadone prescribed and 
number of unsupervised consumption days 
• prevalence of methadone street diversion 
• storage location and security 
• recall of health and pharmacy professional 
information provision around home storage 
• perception of personal and non-patient dan-
gers relating to methadone 
• child awareness of patient consumption of 
methadone 
• estimations of perceived safe amounts for 
accidental paediatric (children and teenag-
ers) consumption 
• actions to take if accidental paediatric con-
sumption of methadone is suspected.
A telephone-administered questionnaire to dis-
pensing pharmacists containing a checklist was de-
vised to collect data on information provision on 
methadone safety, dispensing practices and home 
storage. The content of the questionnaire incorporat-
ed the following aspects;
• amount of methadone patients dispensed to 
in the pharmacy
• provision of take home doses in single large 
containers or as individual daily containers, 
provision of measurement devices and child 
resistant containers
• pharmacist questioning and counselling of 
patients around storage of take home metha-
done 
• need for information leafleting outlining 
risks and precautions regarding take home 
methadone. 
2.4. Sample Description
Consecutive adult patients attending a specialist 
methadone clinic over the course of four weeks com-
pleted the questionnaire which was administered by 
the prescribing team in the specialist clinic as part of 
their regular patient consultations. Participants were 
made aware of the study at one meeting with their 
prescribing doctor and if willing to participate com-
pleted the survey the following week.
Over the four week study period, 96 patients 
were approached to complete the questionnaire and 
only two refused. In total, 94 patients completed the 
questionnaire with a response rate of 98%. Seventy 
six (81%) patients were males, and 18 (19%) were 
females. The majority of respondents were in the 25- 
to 34-age bracket (48 or 51%). 
A telephone interview was conducted with the 
community pharmacists registered as dispensing 
methadone to patients attending the clinic. Forty three 
pharmacists recorded in the specialist clinic register 
as dispensing methadone in the clinic area were con-
tacted. All 43 (100%) pharmacists agreed to complete 
the telephone survey. 
2.4. Ethical Considerations
Ethical approval for the audit was granted by 
Waterford Institute of Technology, Ireland. In terms 
of ethical obligations, in addition to a general expla-
nation of the purpose of the audit, each participant 
was asked to indicate their verbal and written consent 
prior to access, and was assured of their anonymity in 
the study. In terms of the methadone patient survey, 
while the questions asked by the survey administra-
tor could have raised child welfare concerns, they are 
questions which normally would be asked during the 
continuing assessment of patients in receipt of metha-
done replacement by the medical prescriber. The sur-
vey was deemed by the team to provide an oppor-
tune time to discuss the implications of such patient 
knowledge and any risks which may be raised. All 
data collected from participants was anonymised and 
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no personally identifiable data was stored.
3. Results
3.1. Analysis of Data
Analysis was conducted using anonymised data. 
Data analysis involved descriptive statistics, includ-
ing frequencies and percentages. Statistical tests us-
ing SPSS included Chi square tests and p-value were 
used to assess differences in categorical data. A sig-
nificance level of 0.05 was set.
3.2. Methadone Patient Perspectives 
3.2.1. Volume of Methadone Prescribed and Take Home
Patients were asked to indicate the range of 
methadone amount they are prescribed per day. The 
majority of patients were prescribed between 40 ml 
and 59 ml of methadone per day (30 or 32%). Fur-
thermore, females were prescribed methadone be-
tween 20 ml and 99 ml (17 or 100%) with no females 
prescribed methadone in the 0 to 19 ml bracket or the 
100 to 130+ ml bracket.
Methadone was prescribed in instalments, a to-
tal of 61 (65%) patients reported that there was only 
1 day when they did not attend the chemist, 5 (5%) 
patients reported not attending the chemist on 2 days. 
However, 28 (30%) patients received 3 or more doses 
to take home. Furthermore, no one reported attending 
the chemist every day and therefore, all of the sam-
ple were potentially storing methadone at home on at 
least one day.
3.2.2. Street Diversion
A total of 29 (31%) participants admitted buying 
methadone on the street. Seven (39%) of the female 
respondents bought methadone on the street while 
only 22 (29%) of the total male respondents indicated 
that they purchased extra methadone.
3.2.3. Location and Security of Storage
Patients were asked to indicate where they put 
the take-home methadone, until needed (Table 1). 
Forty-three (46%) patients reported storage in a spe-
cific high drawer or storage up high. Other areas in-
cluded in a low drawer (21 or 22%) and in the fridge 
(15 or 16%). Patients were then asked if they put the 
methadone in a locked place. Ten (11%) indicated 
that they placed their methadone in a locked place all 
of the time. This does not concur with Table 1, where 
only 7 confirmed that they used a locked place. Out 
of the 10 above, 1 reported placing the methadone in 
their jacket or handbag, 1 in the bathroom, 1 in a high 
place and 2 in a low drawer. Three (3%) stated that 
they sometimes stored methadone in a locked place 
with 81 (86%) confirming that they do not place their 
take-home methadone in a locked place. Interest-
ingly, none of those who purchased extra methadone 
on the street stored their take-home methadone in a 
locked cabinet.
Table 1: Location of methadone storage
Location Number of patients %
A specific (not locked) high drawer/up high 43 46
A low drawer 21 22
Fridge 15 16
In my jacket/handbag 11 11
Locked place 7 7
Bathroom 2 2
Table 2: Advice on safe storage of methadone at home
Professional Number of patients %
No-one 48 51
Doctor 38 40
Pharmacist 18 19
Counselor 6 6
Social Worker 1 1
Community Drugs Worker 1 1
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placed their methadone in a locked cabinet with 1 
(8%) specifying that they sometimes placed it in a 
secure location. In addition, nine (66%) of this sub-
group indicated that they had been either currently or 
in the past linked with child social services.
Patients were asked to indicate what they felt 
would be a safe amount of methadone for a child un-
der 12 to take by accident. Eighteen (19%) indicated 
that it would be safe for a child to take between 5 
ml to 20 ml of methadone accidentally. When asked 
to indicate what would be a safe amount for a teen-
ager to take accidentally, 30 (32%) patients reported a 
teenager could consume between 5 ml to 30 ml, with 
14 (15%) indicating 20 ml or higher. In response to a 
question relating to what to do first, if you thought a 
child had taken methadone, 85 (90%) indicated that 
they would seek urgent medical help. However, 7 
(8%) reported that they would try to make them sick.
3.3. Methadone Patient Perspectives
Pharmacists were dispensing for a mean of 7 
methadone patients (Range 0 to 48, SD 10.4). Thirty 
(70%) pharmacists reported providing multiple take-
home days in individual daily containers.
3.3.1. Methadone Patient Counselling and Information 
Provision
Twenty five (58%) pharmacists reported never 
questioning methadone patients regarding their stor-
age arrangements for take-home methadone, howev-
er, 25 (58%) stated that they would counsel patients 
on the safe storage of methadone at home and around 
children. Forty one (95%) pharmacists also agreed 
that a standard information leaflet outlining the risks 
and precautions regarding take-home methadone 
would be of benefit.
3.2.4. Sources of Advice on Methadone Storage
Patients were invited to indicate if they had ever 
received advice on safe methadone storage at home 
from different professionals (Table 2). Forty-eight 
(51%) patients reported never being given informa-
tion regarding where they should store their metha-
done. Only 18 (19%) reported that a pharmacist 
advised them. Social workers and community drug 
workers were both only indicated once.
3.2.5. Knowledge of General Dangers of Methadone Use
When asked to indicate if methadone is dan-
gerous to themselves as a user, 33 (35%) replied 
no. However, when subdivided into gender, females 
(17 or 94%) agreed more strongly than males (44 or 
58%) that methadone is dangerous to them as a user. 
A Chi-square test for independence (with Yates Con-
tinuity Correction) indicated a significant association 
between gender and opinion on the danger of metha-
done to a user, χ2 (1, n=94) = 7.0 ,p = 0.008, phi = 
-0.30. A similar question was asked in regard to dan-
gers of methadone to non-users. Ninety one (97%) 
replied yes and only 3 (3%) replied no.
3.2.6. Presence of Methadone in the Home Environment 
and Risks to Children
Thirty (32%) patients reported that they have 
children currently staying in the same accommoda-
tion as them. Seven (23%) of these patients are cur-
rently linked in with child social services, 6 (20%) 
have been linked in to services in the past and 17 
(57%) have never been linked in with social services. 
The subgroup that were linked in with social services 
in the past, reported never placing their take-home 
methadone in a locked place.
Patients were asked if children had ever seen 
them taking methadone in their house. Twelve (13%) 
reported that children had witnessed them taking 
methadone and 11 (92%) of this subgroup never 
Table 3: Performance on Audit Criteria 
Criteria Standards Results
All patients should be aware of the dangers of methadone use. 100% 97%
All patients should be aware of the particular risks to children, especially if they have 
children at home or visiting the home. 100% 53%
All patients prescribed methadone should recall being given information on its safe 
storage. 100% 49%
All methadone should be dispensed in a child resistant container when prescribed for 
home consumption. 100% 95%
All patients with methadone at home should store it in a safe locked location in a 
container with child resistant caps. 100% 7%
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never placed their take home methadone in locked 
storage. In contrast, Mullin et al. [30], reported that 
a majority of their methadone patients with children 
in the home reporting that children were not able to 
access their methadone. Bloor et al. [5] found that 
a minority of patients accepted that children in the 
home would be aware of the storage location. A small 
number of patients in our audit also felt it would be 
safe for a child to consume between 5 and 20 ml 
methadone accidentally. However if accidental con-
sumption was suspected, nearly all would seek urgent 
medical help. Dupuy et al. [12] have underscored 
how parents may not realise dangers for children in 
the event of accidental intoxication and potential for 
death, emergency medical treatment advised, and 
may be fearful of potential social service intervention 
for poor parenting. 
4.2. Patient Safe Storage of Methadone
Acceptable medication storage is defined as out 
of sight and out of reach of children, with optimal 
medication storage when also kept in a secure con-
tainer, and is reportedly more common in patients 
taking higher doses of methadone [42]. Half of pa-
tients reported storage in a specific high drawer or 
storage up high, with other areas including low draw-
ers and fridges, and with a minority placing their 
take-home methadone in a locked place. Methadone 
is most commonly stored at home in cupboards and 
fridges, generally unlocked and dispensed and stored 
in the original, child resistant container [5, 30, 43]. 
Of note, is that none of the patient group (roughly 
a third) who reported street methadone sourcing in 
this Irish audit stored their take-home methadone in 
a locked place. Bloor et al. [5], have reported in their 
audit that patients who did not store their methadone 
at home generally consumed on the street or stored on 
their person or gave to a parent for safekeeping.
4.3. Pharmacy Provision of Information and Patient 
Recall 
Recall of patient information around safety of 
methadone is generally poor in the referred UK au-
dits [30]. Over half of these Irish patients reported 
never being given information regarding where they 
should store their methadone, with a minority refer-
ring to the pharmacist as source. Other audits reveal 
that the majority of methadone patients receive in-
formation from the Methadone Clinic or local drugs 
agency [5]. Over half of the Irish pharmacists in this 
3.3.2. Provision of Containers and Measurement Devices
Of the thirty pharmacists that provided multiple 
take-home days in individual daily containers, twen-
ty (67%) of this subgroup did not usually provide a 
measuring device, however, 9 (30%) would provide it 
on request. In contrast, of the 13 pharmacists that pro-
vided single large containers, 11 (85%) would provide 
a measuring device on request. In a question relating 
to provision of containers with a child-resistant cap, 
41 (95%) of the pharmacists indicated that they al-
ways provide these containers for take-home metha-
done. None of the 43 pharmacists reported reimburse-
ment for provision of these containers, however, all 
43 pharmacists agreed that it would be a good idea to 
provide all take-home methadone in a child-resistant 
container as standard practice. 
3.3.3. Audit Criteria
Performance on criteria 1 to 5 measured against 
the defined standards are shown in table 3. None of 
the criteria reached a 100% standard. However, 97% 
of patients were aware of the dangers of methadone 
use. The patients (53%) that reported storing their 
methadone in a locked place or a specific place such 
as a high drawer or up high were classed as safe loca-
tions and therefore they were said to be aware of the 
risks of methadone to children.
4. Discussion
In this Irish audit, none of the audit criteria 
measuring standards of effective information provi-
sion on safe storage of methadone reached a 100% 
standard. The audit illustrated that whilst dispensing 
practices in child resistant container when prescribed 
for home consumption are adequate, patient recall of 
information on methadone’s safe storage needs to be 
provided regularly both in the pharmacy on dispens-
ing but also at other contact points. The majority of 
patients were prescribed between 40 ml and 59 ml 
of methadone per day, generally reporting one take 
home dose per week. 
4.1. Patient Knowledge of Risk 
Nearly all patients were aware of harm to non-
users, with females reporting greater awareness of 
harm of methadone to the user. Similar levels of pa-
tient knowledge are reported in the UK [5, 30]. 
A third of patients reported having children in 
the home environment, with a small number engaging 
with child social services. Of note was that this group 
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audit never questioned their methadone patients re-
garding their storage arrangements for take-home 
methadone, however, they did report counselling pa-
tients on the safe storage of methadone at home and 
around children. There was agreement that a standard 
information leaflet outlining the risks and precautions 
regarding take-home methadone is warranted. How-
ever, according to Mullin et al. [30], it is unlikely a 
long term methadone patient would recall receiving 
information around safe storage.
4.4. Dispensing Practices of Storage Containers 
and Measurement Devices
The majority of pharmacists provided multiple 
take-home days in individual daily containers, with a 
majority only providing a measurement device on re-
quest. Of the minority providing single large contain-
ers, a majority of this group would provide a meas-
uring device on request. Nearly all always provided 
containers with child resistant caps. In the UK all 
pharmacists in the Mullin et al. [30] audit dispensed 
methadone in a child resistant container, and nearly 
all provided a measuring device on request. 
Limitations
Limitations of the audit centre on its localised 
nature pertaining to the specialist clinic catchment of 
methadone patients in the Cork area, and the conveni-
ence sampling of a diverse range of methadone pa-
tients pertaining to length of treatment regime.
5. Conclusions 
The audit highlighted adequate dispensing prac-
tices in terms of child resistant containers, but under-
scored the need for enhanced pharmacy profession-
als’ vigilance in the advice and counselling role in 
improving patient recall of information, given the low 
reporting of safe and secure home storage, and patient 
awareness of paediatric risk. Studies show that safe 
storage of oral methadone can be improved by con-
sistent provision of safe storage containers with child 
resistance caps, measurement devices to deter use of 
inappropriate devices such as baby bottles, and label-
ling, information around dangers of methadone, risk 
for children and contracting around safety, particular-
ly in the transition period from supervised consump-
tion to unsupervised home consumption regimes [1, 
12, 13, 17, 21, 30]. We emphasize how important re-
peated exposure to safety information must occur at 
several points of contact namely, the addiction clinics, 
and in the day to day transactioning with methadone 
patients in the pharmacy. Strategies focusing on in-
formation provision may be effective in enhancing in-
formed decision-making of patients [35] around safe 
storage. Risk management plans for further develop-
ment in Ireland centre on information campaigns us-
ing printed information material such as leaflets and 
posters for safe storage of methadone containers and 
disposal of used containers after thorough rinsing and 
secure closure. Verbal advice relating to methadone 
is viewed by pharmacists as ‘risky’ compared with 
non-confrontational provision of printed safety mate-
rial supported by verbal provision [25, 30]. The issue 
therefore may present unique potential for extrapola-
tion for novel innovations relating to mobile phone 
based health technology (mHealth) to support the sta-
bilised methadone patient in self-management, with 
safe storage reminders via mobile phone messaging 
[10]. Desire for training and education for pharma-
cists in the delivery of the expanded public health 
role, and substance abuse is also generally warranted 
and desired [34]. 
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